Abstract
Background
Timing of surgical intervention for acute ulcerative colitis has not been fully examined during the modern immunotherapy era. Although early surgical intervention is recommended, historical consensus for “early” ranges widely. The purpose of this study was to evaluate outcomes according to timing of urgent surgery for acute ulcerative colitis.
Methods
All non-elective total colectomies in ulcerative colitis patients were identified in the National Inpatient Sample from 2002 to 2014. Procedures, comorbidities, diagnoses, and in-hospital outcomes were collected using International Classification of Disease, 9th Revision codes. An operation was defined as early if within 24 hours of admission. Results were compared between the early versus delayed surgery groups.
Results
We found 69,936 patients that were admitted with ulcerative colitis, and 2650 patients that underwent non-elective total colectomy (3.8%). Early intervention was performed in 20.4% of patients who went to surgery. More early operations were performed laparoscopically (28.1% versus 23.3%, p = 0.021) and on more comorbid patients (Charlson Index, p = 0.008). Median total hospitalization costs were $20,948 with an early operation versus $33,666 with a delayed operation (p < 0.001). Delayed operation was an independent risk for a complication (OR = 1.46, p = 0.001). Increased hospitalization costs in the delayed surgery group were statistically significantly higher with a reported complication (OR = 3.00, p < 0.001) and lengths of stay (OR = 1.26, p < 0.001).
Conclusion
Delayed operations for acute ulcerative colitis are associated with increased postoperative complications, increased lengths of stay, and increased hospital costs. Further prospective studies could demonstrate that this association leads to improved outcomes with immediate surgical intervention for medically refractory ulcerative colitis.
Similar content being viewed by others
References
Bojic D, Radojicic Z, Nedeljkovic-Protic M, Al-Ali M, Jewell DP, Travis SPL. Long-term outcome after admission for acute severe ulcerative colitis in Oxford: The 1992–1993 cohort. Inflamm Bowel Dis. 2009;15(6):823–8.
Aratari A, Papi C, Clemente V, Moretti A, Luchetti R, Koch M, et al. Colectomy rate in acute severe ulcerative colitis in the infliximab era. Dig Liver Dis. 2008;40(10):821–6.
Clemente V, Aratari A, Papi C, Vernia P. Short term colectomy rate and mortality for severe ulcerative colitis in the last 40 years. Has something changed? Dig Liver Dis. 2016;48(4):371–5.
Zer M, Wolloch Y, Dintsman M. Pitfalls in the surgical management of fulminating ulcerative colitis. Dis Colon Rectum. 1972;15(4):280–7.
Teeuwen PHE, Stommel MWJ, Bremers AJA, Van Der Wilt GJ, De Jong DJ, Bleichrodt RP. Colectomy in patients with acute colitis: A systematic review. J Gastrointest Surg. 2009;13(4):676–86.
Strong S. Management of Acute Colitis and Toxic Megacolon. Clin Colon Rectal Surg. 2010;23(4):274–84.
Caprilli R, Latella G, Vernia P, Frieri G. Multiple organ dysfunction in ulcerative colitis. Am J Gastroenterol. 2000;95(5):1258–62.
Latella G, Vernia P, Viscido A, Frieri G, Cadau G, Cocco A, et al. GI distension in severe ulcerative colitis. Am J Gastroenterol. 2002;97(5):1169–75.
Moore SE, McGrail KM, Peterson S, Raval MJ, Karimuddin AA, Phang PT, et al. Infliximab in ulcerative colitis: the impact of preoperative treatment on rates of colectomy and prescribing practices in the province of British Columbia, Canada. Dis Colon Rectum. 2014;57(1):83–90.
Järnerot G, Hertervig E, Friis-Liby I, Blomquist L, Karlén P, Grännö C, et al. Infliximab as rescue therapy in severe to moderately severe ulcerative colitis: a randomized, placebo-controlled study. Gastroenterology. 2005;128(7):1805–11.
Rutgeerts P, Sandborn WJ, Feagan BG, Reinisch W, Olson A, Johanns J, et al. Infliximab for Induction and Maintenance Therapy for Ulcerative Colitis. N Engl J Med. 2005;353(23):2462–76.
Ross H, Steele SR, Varma M, Dykes S, Cima R, Buie WD, et al. Practice Parameters for the Surgical Treatment of Ulcerative Colitis. Dis Colon Rectum. 2014;57(1):5–22.
Jalan KN, Sircus W, Card WI, Falconer CW, Bruce CB, Crean GP, et al. An experience of ulcerative colitis. I. Toxic dilation in 55 cases. Gastroenterology. 1969;57(1):68–82.
Goligher JC, Hoffman DC, de Dombal FT. Surgical Treatment of Severe Attacks of Ulcerative Colitis, with Special Reference to the Advantages of Early Operation. Br Med J. 1970;4(5737):703–6.
Ausch C, Madoff RD, Gnant M, Rosen HR, Garcia-Aguilar J, Hölbling N, et al. Aetiology and surgical management of toxic megacolon. Colorectal Dis. 2006;8(3):195–201.
Gan S, Beck P. A new look at toxic megacolon: an update and review of incidence, etiology, pathogenesis, and management. Am J Gastroenterol. 2003;98(11):2363–71.
Ananthakrishnan AN, McGinley EL, Saeian K. Outcomes of Weekend Admissions for Upper Gastrointestinal Hemorrhage: A Nationwide Analysis. Clin Gastroenterol Hepatol. 2009;7(3):296–302.
Crowley RW, Yeoh HK, Stukenborg GJ, Ionescu A a, Kassell NF, Dumont AS. Influence of weekend versus weekday hospital admission on mortality following subarachnoid hemorrhage. Clinical article. J Neurosurg. 2009;111(1):60–6.
Bell CM, Redelmeier DA. Waiting for urgent procedures on the weekend among emergently hospitalized patients. Am J Med. 2004;117(3):175–81.
Schilling PL, Campbell DA, Englesbe MJ, Davis MM. A Comparison of In-hospital Mortality Risk Conferred by High Hospital Occupancy, Differences in Nurse Staffing Levels, Weekend Admission, and Seasonal Influenza. Med Care. 2010;48(3):224–32.
Dartmouth Atlas of Health Care. List of ICD-9-CM codes by chronic disease category [Internet]. 2008 [cited 2017 Mar 25]. Available from: http://www.dartmouthatlas.org/downloads/methods/chronic_disease_codes_2008.pdf
Leeds IL, Alturki H, Canner JK, Schneider EB, Efron JE, Wick EC, et al. Outcomes of abdominoperineal resection for management of anal cancer in HIV-positive patients: a national case review. World J Surg Oncol. 2016;14(1):208.
Quan H, Sundararajan V, Halfon P, Fong A, Burnand B, Luthi J-C, et al. Coding algorithms for defining comorbidities in ICD-9-CM and ICD-10 administrative data. Med Care. 2005;43(11):1130–9.
Ferrada P, Velopulos CG, Sultan S, Haut ER, Johnson E, Praba-Egge A, et al. Timing and type of surgical treatment of Clostridium difficile-associated disease. J Trauma Acute Care Surg. 2014;76(6):1484–93.
Gash K, Brown E, Pullyblank A. Emergency subtotal colectomy for fulminant Clostridium difficile colitis—is a surgical solution considered for all patients? Ann R Coll Surg Engl. 2010;92(1):56–60.
Halabi WJ, Nguyen VQ, Carmichael JC, Pigazzi A, Stamos MJ, Mills S. Clostridium difficile colitis in the United States: a decade of trends, outcomes, risk factors for colectomy, and mortality after colectomy. J Am Coll Surg. 2013;217(5):802–12.
Rice-Oxley JM TS. Ulcerative colitis: course and prognosis. Lancet. 1950;1:663–6.
Truelove SC, Witts LJ. Cortisone in ulcerative colitis: final report on a therapeutic trial. Br Med J. 1955;2(4947):1041–8.
Truelove S, Jewell D. Intensive intravenous regimen for severe attacks of ulcerative colitis. Lancet. 1974;303(7866):1067–70.
Jarnerot G, Rolny P, Sandberg-Gertzen H. Intensive intravenous treatment of ulcerative colitis. Gastroenterology. 1985;89(5):1005–13.
Meyers S, Lerer PK, Feuer EJ, Johnson JW, Janowitz HD. Predicting the outcome of corticoid therapy for acute ulcerative colitis. Results of a prospective, randomized, double-blind clinical trial. J Clin Gastroenterol. 1987;9(1):50–4.
Lichtiger S, Present DH, Kornbluth A, Gelernt I, Bauer J, Galler G, et al. Cyclosporine in severe ulcerative colitis refractory to steroid therapy. N Engl J Med. 1994;330(26):1841–5.
Acknowledgements
The authors appreciate biostatistical and data management support from Joseph K. Canner, MS.
Funding
I.L.L.’s contribution to this manuscript was supported by a National Institutes of Health/National Cancer Institute T32 training grant (5T32CA126607) and an American Society of Colon and Rectal Surgeons General Surgery Resident Research Initiation Grant (GSRRIG-131).
Author information
Authors and Affiliations
Contributions
Study design: I.L.L, S.Y.C., J.E.E., S.L.G., B.S., S.H.F.
Data acquisition and analysis: I.L.L., S.Y.C.
Interpretation of data: I.L.L, B.T., A.M.P., S.Y.C., J.E.E., S.L.G., B.S., S.H.F.
Drafting work: I.L.L., S.Y.C., S.H.F.
Critical revision: B.T., A.M.P., J.E.E., S.L.G., B.S.
Final approval and accountability: I.L.L, B.T., A.M.P., S.Y.C., J.E.E., S.L.G., B.S., S.H.F.
Corresponding author
Ethics declarations
This study design was reviewed and approved by the Johns Hopkins Medicine Institutional Review Board.
Appendix
Appendix
We performed propensity score matching described below and repeated a portion of the statistical analysis on high-level findings to confirm that observed differences were not due to limitations of conventional logistic regression analysis. This mirrored analysis is described through the series of complementary tables below. Propensity score assignment and 1:1 nearest neighbor matching with replacement was performed using the teffects package within Stata® 14.2 (StataCorp, College Station, TX). Covariates matched included sex, race, age, income quartile, and Charlson Comorbidity Index group. Patients unable to be matched were excluded from further analysis. A total of 325 patients from the delayed surgery group were individually matched to 539 patients in the early surgery group.
Rights and permissions
About this article
Cite this article
Leeds, I.L., Truta, B., Parian, A.M. et al. Early Surgical Intervention for Acute Ulcerative Colitis Is Associated with Improved Postoperative Outcomes. J Gastrointest Surg 21, 1675–1682 (2017). https://doi.org/10.1007/s11605-017-3538-3
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s11605-017-3538-3